Cargando…
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity
Targeting the Mdm2 oncoprotein by drugs has the potential of re-establishing p53 function and tumor suppression. However, Mdm2-antagonizing drug candidates, e. g. Nutlin-3a, often fail to abolish cancer cell growth sustainably. To overcome these limitations, we inhibited Mdm2 and simultaneously a se...
Autores principales: | Sriraman, Anusha, Radovanovic, Marija, Wienken, Magdalena, Najafova, Zeynab, Li, Yizhu, Dobbelstein, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077964/ https://www.ncbi.nlm.nih.gov/pubmed/27183917 http://dx.doi.org/10.18632/oncotarget.9302 |
Ejemplares similares
-
Mdm2 inhibition confers protection of p53-proficient cells from the cytotoxic effects of Wee1 inhibitors
por: Li, Yizhu, et al.
Publicado: (2015) -
Fortifying p53 – beyond Mdm2 inhibitors
por: Sriraman, Anusha, et al.
Publicado: (2016) -
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
por: Sriraman, Anusha, et al.
Publicado: (2018) -
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a
por: Fontana, Maria Chiara, et al.
Publicado: (2021) -
NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
por: Wu, Nan, et al.
Publicado: (2016)